A detailed history of Dcf Advisers, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Dcf Advisers, LLC holds 130,750 shares of TEVA stock, worth $2.29 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
130,750
Previous 85,000 53.82%
Holding current value
$2.29 Million
Previous $1.2 Million 77.15%
% of portfolio
1.15%
Previous 0.61%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$12.78 - $17.4 $584,685 - $796,049
45,750 Added 53.82%
130,750 $2.12 Million
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $490,820 - $663,780
46,000 Added 117.95%
85,000 $1.2 Million
Q4 2023

Feb 13, 2024

SELL
$8.12 - $10.63 $44,659 - $58,465
-5,500 Reduced 12.36%
39,000 $407,000
Q3 2023

Nov 13, 2023

BUY
$7.48 - $10.7 $41,140 - $58,849
5,500 Added 14.1%
44,500 $453,000
Q2 2023

Aug 09, 2023

BUY
$7.2 - $9.47 $280,800 - $369,330
39,000 New
39,000 $293,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Dcf Advisers, LLC Portfolio

Follow Dcf Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.